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Abstract
Studies using Helicobacter-infected mice show that bone marrow-derived mesenchymal stem cells (MSCs) can repopulate
the gastric epithelium and promote gastric cancer progression. Within the tumor microenvironment of the stomach, pro-
inflammatory cytokine interferon-gamma (IFNc) and Sonic hedgehog (Shh) are elevated. IFNc is implicated in tumor
proliferation via activation of the Shh signaling pathway in various tissues but whether a similar mechanism exists in the
stomach is unknown. We tested the hypothesis that IFNc drives MSC proliferation and recruitment, a response mediated by
Shh signaling. The current study uses transplantation of an in vitro transformed mesenchymal stem cell line (stMSCvect), that
over-expresses hedgehog signaling, in comparison to non-transformed wild-type MSCs (wtMSCs), wtMSCs transfected to
over-express Shh (wtMSCShh), and stMSCs transduced with lentiviral constructs containing shRNA targeting the Shh gene
(stMSCShhKO). The effect of IFNc on MSC proliferation was assessed by cell cycle analysis in vitro using cells treated with
recombinant IFNc (rmIFNc) alone, or in combination with anti-Shh 5E1 antibody, and in vivo using mice transplanted with
MSCs treated with PBS or rmIFNc. In vitro, IFNc significantly increased MSC proliferation, a response mediated by Shh that
was blocked by 5E1 antibody. The MSC population collected from bone marrow of PBS- or IFNc-treated mice showed that
IFNc significantly increased the percentage of all MSC cell lines in S phase, with the exception of the stMSCsShhKO cells. While
the MSC cell lines with intact Shh expression were recruited to the gastric mucosa in response to IFNc, stMSCsShhKO were
not. Hedgehog signaling is required for MSC proliferation and recruitment to the stomach in response to IFNc.
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Introduction
There is a clearly established role for Sonic Hedgehog (Shh)
signaling in the development of cancer [1,2,3]. Cell growth in
digestive tract tumors that include esophagus, stomach, biliary
tract and pancreas are regulated by endogenous expression of
Hedgehog ligands such as Shh [1]. Binding of Hedgehog ligand to
its receptor, Patched (Ptch), results in removal of the inhibition of
Ptch on Smoothened (Smo). This removal of the inhibition on
Smo results in the activation of the Gli-family of Hedgehog
transcription factors and subsequently tumor growth that can be
blocked by Hedgehog neutralizing antibody [1]. While the
association between Shh and gastric cancer is clear, the functional
role of Shh in the development and progression of gastric cancer is
largely unknown. Furthermore, the mechanism that regulates the
production of Shh within the tumor microenvironment has yet to
be determined.
Helicobacter pylori (H. pylori) bacterial colonization causes chronic
inflammation that is consistently associated with the progression to
gastric cancer [4]. The most common and detrimental immune
response involves the Th1 pro-inflammatory cytokines, most
prominently IFNc from T cells, and IL-1b and TNFa from tissue
or invading macrophages [5,6,7,8,9]. Indeed, pro-inflammatory
cytokine IFNc has been shown to contribute to the pathogenesis
and development of gastric metaplasia [5,9,10] and cancer [10]. In
inflammation-induced cancers, the Hedgehog signaling pathway
mediates IFNc-induced tumor development [11,12,13]. In partic-
ular, Shh is an IFNc target gene and Hedgehog signaling a
mediator of IFNc-induced proliferation [12].
During Helicobacter infection, chronic inflammation coincides
with the recruitment of bone marrow-derived mesenchymal stem
cells (BM-MSCs) [14,15]. In the chronically inflamed stomach
BM-MSCs are recruited from bone marrow to the stomach and
differentiate into cancer-associated fibroblasts (CAFs) that are
instrumental in directing cancer development [14]. Although
clearly implicated in the development of gastric cancer, the
mechanism regulating the proliferation and recruitment of
malignantly transformed BM-MSCs to the stomach during
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chronic inflammation is largely unknown. Interestingly, Shh is
reported to induce proliferation and differentiation of BM-MSCs
[16]. Shh has also been recognized as a potential chemoattractant
for bone marrow derived cells when upregulated in response to
chronic inflammation [17,18].
Based on the association between IFNc and Shh, we
hypothesize that IFNc induces Shh signaling within MSCs
facilitating cell migration to the stomach. To test this hypothesis,
the current study compares in vivo BM-MSC recruitment to the
gastric mucosa in response to IFNc using a spontaneously
transformed mesenchymal stem cell line (stMSC) in comparison
to untransformed BM-MSCs. In culture, BM-MSCs are prone to
mutation with aging and exhibit clinically relevant mutations in
the p53 gene [19]. With long-term culture BM-MSCs ‘‘spontane-
ously transform’’ (stMSCs), can be propagated in vitro for
extended periods and exhibit a cancer-promoting phenotype
[19]. The current study uses both stMSCs and untransformed
BM-MSCs (wtMSCs) that over-expresses Hedgehog signaling.
Using the wtMSC and stMSC cell lines both in vivo and in vitro, we
demonstrate that IFNc-induced proliferation and recruitment of
MSC cell lines to the stomach is a response that is mediated by
Shh secretion and signaling.
Materials and Methods
Animals
C57BL/6 (strain #000664) and IRG (strain #008705) mice
used for these studies were purchased from Jackson Laboratories.
All mouse studies were approved by the University of Cincinnati
Institutional Animal Care and Use Committee (IACUC) that
maintains an American Association of Assessment and Accredi-
tation of Laboratory Animal Care (AAALAC) facility.
Bone Marrow-derived Spontaneously Transformed
Mesenchymal Stem Cells (stMSC) and Non-transformed
BM-MSCs (wtMSC) Culture and Treatments
The wtMSC cell lines were established from whole bone
marrow of IRG mice and cultured to passage 5 prior to
transfection with subsequent maintenance at low passage number
(,P10) prior to experimental use. Whole bone marrow was
flushed from the femur and tibia of mice for subsequent culture
and passage of the plastic adherent MSC population [20].
Spontaneously transformed bone marrow-derived mesenchymal
stem cells (stMSCs) transfected with a pDsRed-Hyg-C1 plasmid
expressing red fluorescent protein were used [21]. All cells were
cultured using HyClone DMEM culture media supplemented with
10–15% fetal calf serum and 1% penicillin-streptomycin under
normal conditions. MSCs cultured for treatment were plated in 6
well plates and allowed to grow to 70–80% confluence in normal
media then serum starved overnight. After culture expansion, the
Mouse Multipotent Mesenchymal Stromal Cell Marker Antibody
Panel was used to label MSC cell lines for Sca-1, CD106, CD105,
CD73, CD29, CD44 and the hematopoietic markers CD45 and
CD11b (R&D Systems, SC018). Cells were suspended at a
concentration of 16106 cells/ml and stained according to the
manufacturer’s protocol. Cells were then incubated with Alexa-
Fluor 488 at a 1:100 dilution for 30 minutes at 4uC. Fixation was
performed for 15 minutes at RT using a commercially available
reagent (Invitrogen GAS001S5). Fluorescence intensity was
measured by flow cytometry using the BD FACSCalibur and
CellQuestPro software. wtMSCs and stMSCs were treated with
vehicle, recombinant mouse interferon gamma (rmIFNc, 100 nM,
R&D Systems) or anti-Shh antibody 5E1 (pre-treated for 6 hours)
plus rmIFNc for 24 hours. Treated cells were then analyzed for
changes in the cell cycle by flow cytometry.
Sonic Hedgehog (Shh) Knockdown by Lentivirus-
mediated Short Hairpin RNA (shRNA) using stMSCs
RFP-tagged stMSCs were transduced with five different
MISSION lentiviral transduction particle clones containing
different sequences of shRNA for Shh and a pLKO.1-puro
component conferring puromycin resistance (Sigma Aldrich).
RFP-tagged stMSCs were incubated with lentiviral particles with
ExpressMag magnetic beads (Sigma Aldrich) on a magnet (Oz
Biosciences Super Magnetic Plate, MF10000) for 15 minutes, cells
were removed from the magnet, incubated for a further 16 hours
and then placed under puromycin selection (DMEM Culture
Media containing 10% fetal calf serum, 1% penicillin/streptomy-
cin, 10 mg/mL puromycin) for 7 to 10 days. The effective
puromycin dose needed to eliminate non-transduced cells was
determined previously through a puromycin kill curve that tested
concentrations from 0 to 50 mg/ml (data not shown). Transduced
cells were denoted by a unique clone ID number with cell lines
transduced with shRNA for Shh (stMSCShhKO) numbered 59–63.
A pLKO.1-puro vector transduced RFP-MSC cell line (stMSCvect)
served as the control for the endogenous level of Shh gene
expression. Western blot analysis was used to confirm Shh
knockdown and RFP expression.
Transfection of wtMSCs to Over-express Shh
The plasmid (Origene CW101340) was combined with the
Origene Turbofectin reagent at ratios of 0:1, 1:1, 2:1, 3:1 and 4:1
and incubated for 15 minutes at room temperature. The
transfection reagent was then added drop-wise to wtMSCs at
70% confluence and allowed to incubate for 24 hours before cells
were put under selection in normal media with puromycin. The
effective puromycin dose needed to eliminate non-transfected cells
was determined previously through a puromycin kill curve testing
concentrations from 0 to 10 mg/ml (data not shown). The lowest
concentration that killed all untransfected cells at 3–4 days post
treatment was established as 2 mg/ml.
In vivo stMSC Recruitment and Proliferation
C57BL/6 mice were transplanted with 16106 wtMSCs,
wtMSCsShh, stMSCsvect or stMSCsShhKO via tail vein injection.
Three days after transplantation, mice were injected with vehicle
(sterile PBS, i.p.) or rmIFNc (1 mg/day, i.p.) for 7 or 21 days. Mice
were injected with 200 ml BrdU labeling stock reagent (5-Bromo-
29-deoxy-uridine Labeling and Detection Kit II, Roche Diagnos-
tics, i.p.) 24 hours prior to analysis, and stomach sections fixed in
4% paraformaldehyde, paraffin-embedded and 3 mM sections
prepared for immunohistochemical and immunofluorescence
analyses. Whole bone marrow was also isolated from the femurs
of the same mice with PBS flushing. Red blood cells were lysed
using red blood cell lysis buffer (4.14 g NH4Cl, 0.5 g KHCO3,
0.5 M EDTA in 500 ml, pH 7.2–7,4). Approximately 116106
cells were fixed and permeabilized using Caltag Laboratories Flow
Cytometry Kit, according to the manufacturer’s protocol (Invitro-
gen, GAS-004) and stained using anti-RFP FITC-conjugated
antibody (1:100, Abcam, ab34764) and then stained using Vybrant
DyeCycle Ruby stain (Invitrogen) according to the manufacturer’s
protocol. Fluorescence was analyzed using the BD LSRII Flow
Cytometer system. To analyze specifically the RFP-MSCs, gating
was used to analyze the cell cycle of only the FITC positive cells.
Peak fluorescence was analyzed by ModFitLT software to
Hedgehog and Mesenchymal Stem Cell Proliferation
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determine the percentage of the population in each phase of the
cell cycle.
Flow Cytometry and Cell Cycle Analysis
Cells were serum-starved 16 hours prior to analysis. Cells were
fixed with ice cold 70% Ethanol/PBS for 15 minutes at 220uC,
washed and then stained with propidium iodide for 45 minutes.
The measured values of peak fluorescence per total number of cells
were obtained using the program CellQuest Pro (Becton Dickson).
The percentage of cells from the population in each phase of the
cell cycle was calculated from the peak fluorescence measurements
through analysis with ModFit LT software. Flow cytometry using
the FACSCaliburTM system (Becton Dickson) was performed on
all transduced cells using the Mouse Multipotent Mesenchymal
Stem Cell Marker Antibody Panel according to the manufacturers
protocol (R&D Systems, SC018).
Immunoprecipitation and Western Blot Analysis
Cell lysates were prepared using M-PER mammalian protein
extraction reagent (Thermo Scientific, IL) supplemented with
protease inhibitors (Roche) according to the manufacturer’s
protocol. Media samples from cells were concentrated using
15 mL Amicon Ultra Centrifugal Filter Devices (Millipore). Cell
lysates (100 mg total protein) and media were immunoprecipitated
using anti-Shh 5E1 antibody (2 mg) at 4uC for 16 hours. Protein
A/G agarose beads (20 ml, Santa Cruz Biotechnology, CA) were
added and samples incubated at 4uC for 16 hours. After the 16
hour of incubation, immunoprecipitates were washed 3 times
using PBS and resuspended in 40 ml Laemmli Loading Buffer
containing b-mercaptoethanol (Bio-Rad Laboratories, CA) before
loading onto 4–20% Tris-Glycine Gradient Gels. The gels were
run at 80 V, 3.5 hours, protein transferred to nitrocellulose
membranes at 105 V, 1–2 hours, and then blocked for 1 hour at
room temperature using KPL Detector Block (Kirkegaard & Perry
Laboratories, Inc.). Membranes were incubated overnight at 4uC
with a 1:200 dilution of Shh antibody (N-19, Santa Cruz) followed
by a 1 hour incubation with 1:100 dilution of AlexaFluor anti-goat
680 (Invitrogen). Blots were imaged using a scanning densitometer
along with analysis software (Odyssey Infrared Imaging Software
System).
RNA Isolation and RT-PCR
Total RNA was isolated from stomach tissue using Trizol
reagent according to the manufacturers protocol (TriReagent,
Molecular Research Center, Inc.). The High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems) was used for
cDNA synthesis from RNA following the recommended protocol.
For each sample, 60 ng of RNA was reverse transcribed to yield
approximately 2 mg total cDNA that was then used for RT-PCR.
RFP primer sequences used were as follows: FORWARD –59
CCC CGT AAT GCA GAA GAA GA 39, REVERSE –59 CTT
GGC CAT GTA GGT GGT CT 39. PCR amplifications were
performed in a total volume of 20 ml, containing buffer, 20 mM
forward and reverse primers, Taq polymerase, RNase-free water
and cDNA template. Each PCR amplification was performed in
duplicate wells in a GeneAmp PCR System 9700 thermocycler
(Applied Biosystems), using the following conditions: 94uC 3
minutes, 94uC 30 seconds, 60uC 1 minute and 72uC 1 minute for
35 cycles. PCR products were visualized on a 1.5% agarose TAE
gel.
Immunohistochemistry
Mice were injected with 200 ml of BrdU labeling stock reagent
(5-Bromo-29-deoxy-uridine Labeling and Detection Kit II, Roche
Diagnostics) 24 hours prior to analysis. Gastric tissues were fixed
with Carnoy’s fixative (60 ml ethanol, 30 ml chloroform, 10 ml
acetic acid) for 16 hours, paraffin embedded, and 4 mm sections
were prepared. After deparaffinization, antigen retrieval was
performed by heating the slides for 10 minutes at 100uC in 0.01 M
sodium citrate buffer (Antigen Unmasking Solution, Vector
Laboratories, Burlingame, CA). Endogenous peroxidase activity
was then blocked by incubating slides in 3% hydrogen peroxide/
ethanol for an additional 20 minutes. Sections were then blocked
using 5% BSA/Tris buffered saline/0.1%Tween 80 (TBS-T) and
incubated with a 1:20 dilution of anti-BrdU antibody (5-Bromo-29-
deoxy-uridine Labeling and Detection Kit II, Roche Diagnostics)
at 37uC for 30 minutes. BrdU color development was performed
according to manufacturer’s protocol. Sections were then blocked
with 20% normal goat serum for 20 minutes and incubated with a
1:400 dilution of biotin-conjugated anti-RFP antibody (Abcam,
ab34771) for 16 hours at 4uC followed by 1:500 dilution of anti-
rabbit IgG for 30 minutes and then visualized with avidin-biotin
complexes using the Vectastain Elite ABC Kit using diamino-
benzidine (DAB) as the substrate (Vector Laboratories, Inc.,
Burlingame, CA). Slides were mounted using Permount.
For adipocyte induction, stMSCs were treated with HyClone
DMEM containing1028 M dexamethasone (Sigma, D4902) and
5 mg/ml insulin (Sigma, I6634). All cells were fixed using 4%
paraformaldehyde for 20 minutes at RT. To detect differentiation,
Oil Red O staining was performed by adding a 3.75% Oil Red O
solution, incubating 5 minutes at RT, then washing in water
before mounting on slides using Vectashield HardSet Mounting
Medium. Images were viewed and captured under light micros-
copy using an Olympus BX60 with a Diagnostic Instruments
‘‘Spot’’ Camera.
Immunofluorescence
stMSCvect and stMSCShhKO cells were grown on coverslips until
70–80% confluency, fixed with 4% paraformaldehyde for 30
minutes at room temperature, permeabilized with PBS containing
0.5% TritonX-100 and blocked with 2% donkey serum for 1 hour
at room temperature. Cells were then incubated with either a 1:50
dilution of anti-CD44 (Abcam ab65829) or a 1:100 dilution of
anti-CD45 (Abcam ab10558) antibody overnight at 4uC. Alexa
Fluor donkey anti-rabbit 488 was used as the secondary antibody
at 1:1000 dilution for 1 hour at room temperature. Cells were then
counterstained with a 1:2000 dilution of the nuclear stain TO-
PRO 3-iodide (Invitrogen, T3605) for 20 minutes at RT before
mounting using Vectashield HardSet Mounting Medium. Rabbit
IgG was used at a 1:25 dilution as a negative control under the
same conditions.
Stomach sections collected from PBS or IFNc treated mice were
blocked with 20% normal goat serum and incubated with 1:400
anti-RFP antibody (Abcam, ab34771) for 16 hours at 4uC followed
by 1:100 anti-rabbit Alexa Fluor 488 (Invitrogen) secondary
antibody for a further 1 hour. Slides were then counterstained
using anti-E-cadherin (BD Transduction Labs, 610181) antibody
at a 1:200 dilution for 1 hour at room temperature followed by
1:100 anti-mouse Alexa Fluor 633 (Invitrogen) secondary
antibody. All samples were mounted using Vectashield Hardset
Mounting Medium (VectaLabs). Images were obtained using a
Zeiss LSM510 META confocal microscope.
Hedgehog and Mesenchymal Stem Cell Proliferation
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Chemotaxis Assay
The chemotaxis assay was performed based on established
protocols [22]. Transduced stMSCs were plated in 24 well
transwell plates containing PET membranes with 8 mm pores (BD
Falcon). 2.56104 cells were seeded in the apical (upper) chamber
in DMEM media containing 0.1% BSA. SDF-1a (rmSDF-1a,
R&D Systems) was added to the basolateral (lower) chamber at
concentrations of 0 to 150 ng/ml. Cells were incubated for 6 hours
at 37uC. After migration, cells were fixed in 4% paraformaldehyde
for 30 minutes then stained for 10 minutes using a Wright-Giemsa
stain. Cells remaining on the top of the membrane were removed
with a cotton-tipped applicator and remaining cells were counted
in 5 fields at 406magnification. The number of migrating cells
was calculated by dividing the average number of migrating cells
in each well by the average number of migrating cells in the
control well.
Statistical Analysis
Results were analyzed by either a student’s unpaired t test or
ANOVA using commercially available software (GraphPad Prism,
GraphPad Software, San Diego, CA). A P value ,0.05 was
considered significant.
Results
IFNc-induced stMSC Proliferation is Mediated by Shh
Secretion and Signaling
The role of Hedgehog signaling as a mediator of IFNc-induced
stMSC and wtMSC proliferation was identified by flow cytometry
and cell cycle progression. After treatment, cells were stained with
propidium iodide and cell cycle analyzed by flow cytometry on a
selected single cell population (Figure S1A). Figure 1 represents
the mean values of cell distribution percentage at different cell
cycle phases in the treatment groups shown in Figures S1B–E.
Figures S1B–E represent plots showing the changes in the cell
cycle phases. The mean values and statistical significance in
response to all treatments is summarized in Figure S1F and G.
Analysis of the raw fluorescence data showed an increased
percentage of stMSCs in S phase and G2/M phase, and a
reduced percentage of cells in G0/G1 phase in response to rmIFNc
compared to the vehicle-treated cells (Figure 1A). To identify the
role of secreted Shh as a mediator of IFNc-induced stMSC
proliferation we used anti-Hedgehog neutralizing 5E1 monoclonal
antibody which binds to Shh ligand and disrupts protein binding
to the receptor Ptch [1]. The proliferative response of stMSCs to
rmIFNc was significantly inhibited with 5E1 antibody treatment
(Figure 1A). When compared to the stMSCs, non-transformed
wtMSCs responded similarly in response to IFNc suggesting the
observed increase in proliferation was not the result of transfor-
mation alone. IFNc significantly induced the percentage of
wtMSCs in S phase, a response that was blocked by anti-Shh
antibody (Figure 1B). Collectively, Figure 1 demonstrates that
IFNc induces proliferation of both untransformed and spontane-
ously transformed MSCs, a response that is mediated by secreted
Shh.
Silencing the Shh Gene within Bone Marrow-derived
stMSCs
To comprehensively study the role of Hedgehog signaling in
BM-MSC proliferation and recruitment in vivo, wtMSCs were
transfected to over-express Shh while stMSCs were transduced
with lentiviral shRNAs against Shh. A pLKO.1-puro base
lentiviral vector expressing a short hairpin sequence against the
transcript of the Shh gene was used. Control MSC cell lines were
established by using wtMSC with endogenous expression of Shh
and transfection of stMSCs with the pLKO.1-puro base lentiviral
vector (stMSCvect). Five lentiviral clones, each clone expressing a
different short hairpin sequence, were analyzed (stMSCShhKO59-
stMSCShhKO63). Knockdown of Shh was confirmed by Western
blot analysis that showed 100% knockdown of Shh protein
expression in all clones compared to the untransduced cells
(wtMSCs) and Shh over-expressing cell lines (wtMSCShh and
stMSCvect) (Figure S2A). Clone stMSCShhKO59 was used for
subsequent experiments and will be referred to as stMSCShhKO.
Expression of pDsRed-Hyg-C1 plasmid expressing red fluorescent
protein (RFP) was confirmed by immunoblot using cell lysate
collected from transduced stMSCs (Figure S2A). Importantly,
wtMSCs stably transfected to over-express Shh protein, expressed
Shh at a level similar to the stMSCs (Figure S2A).
To verify knockdown of Shh in MSCs without altering the
differentiation of the cells, an expression pattern for the classical
CD markers (CD29, CD106, CD105, CD44 and CD73) and Sca-
1 using flow cytometry was performed using cultured stMSCvect
(Figure S2B) and stMSCShhKO (Figure S2C) cells. Both
stMSCvect and stMSCShhKO cells were negative for CD45 (Figure
Figure 1. Effect of IFNc on wtMSC and stMSC cycle progression.
Cells were stained with propidium iodide and cell cycle analyzed by
flow cytometry. The data were calculated from the cell cycle phase
analysis by MODFIT software showing changes in distribution of G0/G1,
S and G2/M phases from (A) stMSC- or (B) wtMSC-treated with vehicle
(Veh), IFNc, anti-Shh 5E1 antibody (5E1) and 5E1 plus IFNc. Mean values
from 4 individual experiments are shown.
doi:10.1371/journal.pone.0075225.g001
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S3). Additionally, both stMSC cell lines were able to differentiate
to an adipocyte phenotype based on positive Oil Red O staining of
lipid droplets produced (Figure S3). Collectively, these data
suggest that knockdown of Shh protein in stMSCs did not change
the differentiation of these cells.
IFNc Induces Proliferation of wtMSCs and stMSCs in Bone
Marrow
To determine the effect of IFNc on wtMSC and stMSC
proliferation in vivo, mice were transplanted with RFP-tagged
wtMSC, wtMCSShh, stMSCvect or stMSCShhKO cells and treated
with rmIFNc for 21 days. After IFNc treatment, bone marrow was
harvested and analyzed for changes in cell cycle and number of
RFP-positive cells by flow cytometry. IFNc induced a significant
increase in the number of RFP positive cells within the bone
marrow of all experimental groups except for those animals
transplanted with stMSCShhKO cells (Figure 2A, B). Immunoflu-
orescence of bone marrow revealed that there was a significant
increase specifically in the number of proliferating RFP positive
cells in response to IFNc as co-localized by BrdU immunostaining
(Figure 2C, D). This was further supported by Figure S4A, B
and C that shows representative light-scatter analysis revealing a
population of stMSCs that were positive for RFP and comprised
approximately 0.1% of the entire bone marrow cell population.
RFP-positive cells were gated for the single cell population
(Figure S4C) and cell cycle analyzed. Cells collected from the
bone marrow of mice transplanted with stMSCvect cells treated
with rmIFNc had a significantly greater percentage of cells in S-
phase (55.562.82%) compared to those mice treated with PBS
(32.965.14%, P,0.05 compared to stMSCvect transplanted mice
treated with PBS) (Figure S4F). The percentage of cells in S-
phase collected from the bone marrow of mice transplanted with
stMSCShhKO treated with rmIFNc were not significantly different
(32.962.64%) compared to those mice treated with PBS
(38.461.47%, P.0.05 compared to stMSCShhKO transplanted
mice treated with PBS) (Figure S4I). Figures S4D, E, G and H
represent plots showing the changes in the cell cycle phases. Thus,
IFNc induces proliferation of both wtMSCs and stMSCs in vivo
within the bone marrow, a response that appears to be mediated
by Shh signaling.
In vivo Recruitment of wtMSCs and stMSCs to the Gastric
Mucosa in Response to IFNc
To identify the role of Hedgehog signaling as a mediator of
IFNc-induced stMSC recruitment to the gastric epithelium, mice
transplanted with stMSCvect and stMSCShhKO cells were treated
with PBS or IFNc for 21 days. Stomachs were then collected and
recruitment of RFP-tagged stMSCvect and stMSCShhKO cells
analyzed by immunohistochemistry (Figure 3). stMSCvect cells
were recruited to the gastric mucosa of mice injected with IFNc
(Figure 3C, D) compared to the absence of RFP-tagged
stMSCvect cells in the stomachs of PBS-injected mice
(Figure 3A, B). stMSCShhKO cells transplanted into mice injected
with IFNc were not recruited to the gastric mucosa (Figure 3E,
F). Expression of RFP-tagged stMSCvect cells with IFNc treatment
was confirmed by RT-PCR (Figure 3G). To identify whether
recruitment of MSCs to the gastric mucosa in response to IFNc
was unique to the stMSCs, the experiment was repeated using
either wtMSCs or wtMSCs over-expressing Shh (wtMSCShh).
Although both wtMSC and wtMSCShh cells were detected in the
stomachs of IFNc-treated mice, there were significantly higher
numbers of wtMSCShh and stMSCvect cells within the gastric
mucosa when compared to the wtMSC cell transplanted group
(Figure 3H). Collectively, these data suggest that Shh signaling is
likely to mediate the recruitment of MSCs to the gastric mucosa in
response to IFNc.
There was a significant increase in the number of proliferating
cells within the gastric mucosa in response to IFNc-treated
wtMSCShh and stMSCvect transplanted mice compared to the
PBS-injected mice (Figure 4A–D, Figure S5A–F). However,
MSCs were BrdU negative (Figure 4B, C and Figure S5A–D).
Although stMSCShhKO cells transplanted into mice injected with
IFNc were not recruited to the gastric mucosa, there was no
difference in epithelial proliferation between PBS and IFNc
treatments in this experimental group, suggesting increased MSC-
derived Shh may be required to support this increased prolifer-
ation (Figure 4D). In addition, although wtMSCs were recruited
to the gastric mucosa in response to IFNc, there was no difference
in epithelial proliferation between the PBS and IFNc treatments
(Figure 4D). These data suggest that Shh signaling within
wtMSCsShh and stMSCs in response to IFNc induces proliferation
within the gastric epithelium. IFNc alone, in the absence of
stMSCs, does not induce proliferation within the gastric mucosa
confirming this effect is not related to inflammation alone.
To determine whether decreased stMSC proliferation, after
recruitment, was associated with cell adhesion within the gastric
epithelium, stomachs were then co-stained for E-cadherin and
RFP (Figure 4G–I). PBS-treated mice that were transplanted
with RFP-tagged stMSCvect cells showed no recruitment of cells to
the gastric mucosa (Figure 4G). Consistent with Figure 3, IFNc-
injected mice that were transplanted with RFP-tagged stMSCvect
cells showed marked recruitment of cells to the gastric mucosa
(Figure 4H). RFP-tagged stMSCVect cells co-localized with E-
cadherin (Figure 4G, I) supporting that recruited cells had
engrafted within the gastric epithelium.
Hedgehog Signaling Mediates the Expression of Focal
Adhesion Protein in Response to SDF-1a Chemokine
We chose to investigate the SDF-1a/CXCR4 signaling axis as it
has been established that this signaling pathway promotes MSC
recruitment [23,24]. There was a significant increase in circulating
SDF-1a concentrations in all experimental groups in response to
exogenous IFNc (Figure 5A). Other cytokines such that included
IL-11, IL-6, GM-CSF, IL-1b, TNFa and TGFb were measured
by LuminexH assay. We did not see any significant changes in
these cytokines in response to exogenous IFNc (data not shown).
To begin to identify the mechanism by which Hedgehog signaling
regulates MSC recruitment, we analyzed the migration of
transduced stMSCvect and stMSCShhKO cells in response to the
chemokine SDF-1a (Figure 5B). While stMSCvect cells migrated
toward SDF-1a, transduced stMSCShhKO cells did not
(Figure 5B).
Formation of actin stress fibers is a critical step for MSC
migration [24]. Therefore we examined the effect of SDF-1a on
cytoskeletal reorganization in stMSCvect and stMSCShhKO cells.
Actin stress fiber formation was observed in stMSCvect cells
stimulated with SDF-1a (Figure 5C) compared to the untreated
stMSCvect cells (Figure 5D). This organization was completely
disrupted in stMSCShhKO cells treated with SDF-1a (Figure 5F)
when compared to the untreated stMSCShhKO cells (Figure 5E).
Disruption in the F-actin reorganization initiated by SDF-1a
stimulation may explain the inability of stMSCShhKO cells to
migrate in response to the SDF-1a gradient. Cell migration relies
on the activation of tyrosine kinases such as focal adhesion kinase
(FAK) and paxillin [24]. We observed a rapid transient increase in
phosphorylated FAK and phosphorylated paxillin in all SDF-1a-
treated cell lines except for stMSCShhKO cell (Figure 5G–J). This
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Figure 2. wtMSC and stMSC proliferation within the bone marrow compartment of mice injected with IFNc. Flow cytometric analysis of
bone marrow isolated from mice transplanted with wtMSC, wtMSCShh, stMSCsvect or stMSCsShhKO treated with rmIFNc for 21 days. (A) Light-scatter
analysis revealing an increase in RFP-positive MSCs in response to IFNc. (B) Percentage of RFP-positive cells was quantified based on flow cytometric
analysis. *P,0.05 compared to PBS-treated group, n = 4 mice/group. Representative immunofluorescence stain of RFP (green)- and BrdU (red)-
positive cells within the bones collected from mice transplanted with stMSCsvect treated with (C) PBS or (D) rmIFNc for 21 days. Images captured at
106magnification, insets captured at 406magnification. Scale bar = 50 microns.
doi:10.1371/journal.pone.0075225.g002
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transient activation correlated with the re-organization of F-actin
filaments shown in the representative Figures 5C and D. It is
known that the SDF-1a/CXCR4 signaling axis is largely
responsible for the homing of bone marrow-derived mesenchymal
[23,24]. The loss of ability to migrate and activation of focal
adhesion kinases that was associated with silencing of Shh
Figure 3. RFP-tagged stMSCvect cells within the gastric mucosa of mice treated with IFNc. Gastric mucosa collected from mice
transplanted with stMSCvect cells injected with (A, B) PBS or (C, D) IFNc or with stMSCShhKO cells injected with (E, F) IFNc were stained with anti-RFP
antibody (brown). Higher magnification of image in (A, C and E) are shown in (B, D and F). (G) RT-PCR using RNA isolated from stomachs of PBS- or
IFNc-treated mice transplanted with stMSCvect or stMSCShhKO cells. (H) Morphometric analysis of RFP-positive cells/gland in the stomachs of mice
transplanted with wtMSC, wtMSCShh, stMSCsvect or stMSCsShhKO treated with rmIFNc for 21 days. *P,0.05 compared to the wtMSC group, n = 4 mice/
group. Images A, C and E captured at 206magnification and images B, D and F captured at 1006magnification. Scale bar = 50 microns.
doi:10.1371/journal.pone.0075225.g003
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expression suggests that Hedgehog is a key factor in this signaling
cascade.
Discussion
Sonic Hedgehog (Shh) secreted in response to IFNc induced the
proliferation of stMSCs within the bone marrow that may play a
role in the malignant transformation of BM-MSCs as well as their
tropism for sites of chronic inflammation. In culture, BM-MSCs
are susceptible to p53 point mutations [19]. Normally BM-MSCs
do not exhibit malignant properties, but with long-term culture
BM-MSCs ‘‘spontaneously transform’’ (stMSCs) [19]. The
stMSCs acquire cancer-promoting properties and interestingly
have significantly increased growth kinetics [19,25]. Moreover, in
the chronically inflamed stomach BM-MSCs are recruited from
bone marrow and contribute to a population of cancer-associated
fibroblasts (CAFs) that are believed to drive cancer development
[14]. Taken together with our findings demonstrating the rapid
proliferation of both wtMSCs and stMSCs in response to IFNc, we
Figure 4. Proliferation of RFP-tagged stMSCvect cells within the gastric mucosa. Gastric mucosa collected from mice transplanted with
stMSCvect cells injected with (A) PBS or (B, C) IFNc were BrdU labeled (blue) and co-stained with anti-RFP antibody (brown). Higher magnification of
image in (B) is shown in (C). (D) BrdU-labeled cells were quantified in the fundus. Cells were counted under 206magnification. *P,0.05 compared to
PBS-injected group, n = 4–6 mice/group. Confocal images of immunofluorescence staining for E-cadherin (E-cad, Alexa Fluor 633, red) and RFP (Alexa
Fluor 488, green) mice transplanted with stMSCvect cells injected with (G) PBS or (H) IFNc. Higher magnification of image in (H) is shown in (I). Images
A and B captured at 106magnification and image C captured at 406magnification. Scale bar = 50 microns.
doi:10.1371/journal.pone.0075225.g004
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may speculate that during chronic inflammation IFNc induces
Shh secretion. Shh then acts via an autocrine regulatory
mechanism to stimulate the rapid proliferation of MSCs within
the bone marrow that could contribute to critical gene level
changes and malignancy. These findings may have significance in
aging and increased susceptibility to cancer development.
The expression of Shh protein within stMSCs was crucial for
cell migration. In addition, there was a significant increase in
circulating chemokine stromal cell-derived factor-1 (SDF-1a)
concentrations in response to exogenous IFNc in all experimental
groups. Consistent with our observation, SDF-1a is known to
promote the migration of human MSCs [24,26]. With inflamma-
tion, the gastric mucosa exhibits increased levels of SDF-1 as a
result of the production of hypoxia inducible factors and activation
of the SDF-1/CXCR4 axis regulates the recruitment of stromal
cells during the early stages of carcinogenesis [23,27]. While
discovering that MSCs are responsible for the development and
progression of gastric carcinoma, the inflamed gastric mucosa
exhibits increased levels of SDF-1a [15]. SDF-1a binds to its
receptor CXCR4 to activate the Jak2/STAT3 and ERK1/2
signaling pathways that in turn regulate focal adhesion kinases
(FAKs). Activation of FAKs subsequently induces reorganization
Figure 5. Focal adhesion kinase expression in wtMSCs and stMSCs in response to SDF-1a. (A) Circulating SDF-1a concentrations in
plasma collected from mice transplanted with wtMSC, wtMSCShh, stMSCsvect or stMSCsShhKO treated with rmIFNc for 21 days. (B) Migration assay
using stMSCvect and stMSCShhKO cells in response to chemokine SDF-1a at concentrations between 0 to 200 ng/ml. *P,0.05 compared to stMSCShhKO
cells, n = 3 expts. F-actin re-organization in stMSCvect and stMSCShhKO cells in response to SDF-1a. Immunofluorescence using an antibody specific for
F-actin (Alexa Fluor 488, green) and nuclear marker (TO-PRO 633, red) of (C, E) stMSCvect and (D, F) stMSCShhKO cells treated with SDF-1a. Arrows in E
show actin stress fibers in stMSCvect cells in response to SDF-1a. Immunoblots of FAK and paxillin protein expression in (G) stMSCvect, (H) stMSCShhKO,
(I) wtMSC and (J) wtMSCShh cells treated with SDF-1a. Images captured at 406magnification. Scale bar = 10 microns.
doi:10.1371/journal.pone.0075225.g005
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of the actin cytoskeleton that promotes human MSCs migration
[24]. There were marked differences between F-actin expression
and activation of FAK and paxillin and the phosphorylated forms
of these proteins between wtMSCs, wtMSCShh and stMSCvect
compared to the stMSCShhKO cells in our studies. While SDF-1a
induced actin stress fibers and activation of FAK in wtMSC,
wtMSCShh and stMSCvect cells consistent with migration,
stMSCShhKO cells exhibited a disorganized cytoskeleton, lack of
phosphorylated FAK and paxillin in response to the chemokine,
and failed to migrate to the gastric mucosa. Our data may suggest
a role for Shh signaling in trafficking of the CXCR4 receptor to
the membrane resulting in actin cytoskeletal reorganization
leading to the migration of transformed MSCs from the bone
marrow and recruitment to the stomach. It is well established that
the CXCR4/SDF-1 pathway is implicated in the recruitment of
MSCs to sites of injury as well as to areas of tumor development
[24,28,29]. What emerges from this body of work is a plausible
mechanism for the inflammation-initiated recruitment of MSCs to
the stomach that is mediated by Hedgehog signaling.
Once recruited to the gastric mucosa in response to IFNc, RFP-
tagged wtMSCs and stMSCs were not actively proliferating but
had adhered to the gastric epithelium, which was confirmed by the
expression of E-cadherin. Consistent with published data, recruit-
ed stMSCvect cells often appeared as single-scattered cells adhered
to the gastric epithelium [15,21,30]. In vitro studies demonstrate
that bone marrow-derived MSCs treated with gastric extract
acquire an epithelial morphology that express the epithelial cell
marker cytokeratin 19 and multiple gastric genes [30]. When
injected into the adult stomach or early blastocysts MSCs give rise
to gastric epithelial cells that may represent epithelial progenitor
cells that are uncommitted to a particular cell lineage [30]. In the
setting of chronic Helicobacter infection, bone marrow-derived cells
repopulate the gastric mucosa and become engrafted within
dysplastic glands and contribute to malignant progression [15].
Moreover, in mammary tissue under conditions of inflammation,
MSCs acquire a cancer phenotype, while neoplastic dormancy was
achieved with neutralization of the host’s inflammatory response
[25]. Although exogenous IFNc treatment causes gastritis and
parietal cell atrophy [5], the duration of treatment (28 days) is not
sufficient to cause dysplasia. Therefore, it was difficult from our
current experiments to determine the role of MSCs within the
stomach once recruited. However, our data does show that MSCs
express and secrete Shh and that the Hedgehog signaling pathway
is crucial for the recruitment to the stomach in response to IFNc.
In addition, the experimental groups that over-expressed Shh
within MSCs (i.e. wtMSCShh and stMSCvect cells) correlated with
significantly increased epithelial proliferation once recruited to the
gastric mucosa. Thus, the question that remains to be answered
from the current and previous studies is the role of recruited MSCs
within the stomach, whether untransformed or malignant.
With H. pylori infection T-lymphocytes recruited to the stomach
produce IFNc. During infection, IFNc may trigger MSCs in the
bone marrow to secrete elevated levels of Shh. Activation of this
signaling pathway has a two-fold effect of not only increasing the
proliferative capacity of MSCs but also increasing the ability to
migrate in response to SDF-1a. However, once MSCs are
recruited to the stomach, further studies are required to determine
whether the inflammatory environment and Hedgehog signaling
provide continual support for gastric carcinogenesis.
Supporting Information
Figure S1 Effect of IFNc on stMSC cell cycle. (A) Cells
were stained with propidium iodide and cell cycle analyzed by flow
cytometry on the single cell population. Flow cytometry graphs
generated from cell cycle phase analysis by MODFitLT software
showing changes in distribution of G0/G1, S and G2/M phases
from stMSCs treated with (B) vehicle, (C) IFNc, (D) immunoneu-
tralizing anti-Shh 5E1 antibody (5E1) and (E) 5E1 plus IFNc. The
G0/G1 and G2/M phases are indicated as the two major peaks
with arrows. The shaded blue area between the major peaks (G0/
G1, G2/M phases) is the S phase. Cell cycle analysis by FACS
showing changes in distribution of G0/G1, S and G2/M phases of
all experimental groups that included (F) stMSCs and (G)
wtMSCs treated with vehicle, IFNc, anti-Shh 5E1 antibody and
5E1 plus IFNc. *P,0.05 compared to vehicle-treated cells, n = 4
individual experiments.
(TIF)
Figure S2 Transduction and transfection of MSCs. (A)
Western blot analysis demonstrating reduced expression of Shh in
cultured, transduced stMSC clones compared to untransduced
stMSCsWT. All available lentiviral constructs, each expressing a
unique shRNA sequence targeting Shh gene expression, were
assessed and were equally effective. They are denoted by the
unique numbers within the clone ID numbers assigned by the
manufacturer (ShhKO59-ShhKO63). Shh protein expression in
media collected from cultured wtMSC, wtMSCShh, stMSCvect and
stMSCShhKO cells confirming endogenous or over-expression of
Shh. Flow cytometric analysis of MSC-specific cell surface markers
for (B) stMSCsvect and (C) stMSCsShhKO.
(TIF)
Figure S3 Differentiation of the transduced stMSCvect
and stMSCShhKO cell lines. (A) stMSCvect and (B) stMSCShhKO
cells were stained with Oil Red O, with positive, red staining
indicating lentiviral transduction does not affect stMSC ability to
differentiate along normal cell lineages. stMSCvect and
stMSCShhKO cells were stained using IgG control (C, D), and
were positive for the MSC marker CD44 (E, F) and negative for
the hematopoietic stem cell marker CD45 (G, H).
(TIF)
Figure S4 In vivo stMSC proliferation within the bone
marrow compartment of mice injected with IFNc. Flow
cytometric analysis of bone marrow isolated from mice trans-
planted with stMSCsvect or stMSCsShhKO treated with rmIFNc for
7 days. (A, B) Light-scatter analysis revealing a population of
RFP-positive stMSCs. (C) RFP-positive cells were gated. Flow
cytometric graphs generated from cell cycle phase analysis by
MODFitLT software showing changes in distribution of G0/G1, S
and G2/M phases from mice transplanted with stMSCvect cells
treated with (D) PBS and (E) IFNc, or with stMSCShhKO cells
treated with (G) PBS and (H) IFNc. Graph generated from cell
cycle phase analysis showing changes in distribution of G0/G1, S
and G2/M phases from mice transplanted with (F) stMSCvect or (I)
stMSCShhKO cells treated with PBS and IFNc. Data shown as
mean 6 SEM, n= 3–4 mice per group.
(TIF)
Figure S5 Shh-expressing MSCs recruited to the gastric
epithelium promote cell proliferation within the isth-
mus region. Representative gastric sections isolated from mice
transplanted with (A, B) wtMSC, (C, D) wtMSCShh, stMSCvect
and (E, F) stMSCShhKO cells were stained using antibodies against
BrdU (blue) and RFP (brown). RFP positive MSCs (brown) were
recruited to the gastric mucosa in response to IFNc in the (B)
wtMSC and (D) wtMSCShh transplanted groups but this
recruitment was lost in the (F) stMSCShhKO transplanted groups.
In groups with MSC recruitment in response to IFNc (B, D),
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BrdU (blue) and RFP (brown) staining do not overlap, although
the number of proliferating cells increase, suggesting recruited
MSCs do not represent the proliferative population but instead
promote gastric epithelial cell proliferation. Images captured at
106magnification. Scale bar = 50 microns.
(TIF)
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